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ABSTRACT 
 
CHARACTERIZATION OF PROTEIN-PROTEIN INTERACTION WITHIN A 
POLYAMINE RESPONSIVE SIGNALING SYSTEM IN VIBRIO CHOLERAE 
 (August 2012) 
Samuel Sparrow Pendergraft, B.S., Appalachian State University 
M.S., Appalachian State University 
Thesis Chairperson: Ece Karatan 
The Gram-negative bacterium Vibrio cholerae is a natural inhabitant of aquatic 
environments and the causative agent of the severe diarrheal disease cholera. This 
bacterium is able to form biofilms on both abiotic surfaces and on the biotic surfaces of 
chitinous zooplankton. Biofilm formation is vital to the survival of V. cholerae both 
within aquatic reservoirs and during transmission to the human host. The bacterial second 
messenger cyclic-di-GMP is an important signaling system that is known to regulate 
biofilm formation in response to environmental signals. Previous research investigating a 
putative c-di-GMP-signaling pathway involving the periplasmic protein NspS and the 
GGDEF-EAL protein MbaA, revealed that the polyamines spermidine and norspermidine 
likely act as specific extracellular environmental signals to modulate NspS-MbaA 
interaction and affect biofilm formation. These proteins have opposite effects on biofilm 
formation in vitro and are encoded by adjacent genes with overlapping reading frames as 
part of an operon structure.  
 The objective of this study has been to provide evidence of direct protein-protein 
interaction between NspS and MbaA, and to further elucidate the molecular details of the 
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putative norspermidine/spermidine-MbaA/NspS signaling system in V. cholerae. Our 
results further characterize the role periplasmic polyamine-binding proteins play in 
cyclic-di-GMP-mediated signal transduction within the first polyamine-responsive 
signaling system identified in bacteria. 
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INTRODUCTION 
 
 The Gram-negative proteobacterium Vibrio cholerae exists as both a free-
living environmental fauna organism and a human intestinal pathogen. This bacterium is 
the causative agent of the severe diarrheal disease cholera, and a natural inhabitant of 
oceans, lakes, rivers, and estuaries where it is believed to exist predominantly as matrix-
enclosed, surface-associated communities known as biofilms (Colwell and Huq, 1994). 
Biofilms are composed of bacteria embedded in a matrix of  proteins, DNA, and an 
exopolysaccharide made up mainly of galactose and glucose (Yildiz & Schoolnik, 1999). 
Biofilms confer a marked survival advantage in hostile environments by providing 
protection against damaging sources such as antibiotics, pH changes including those 
within the human digestive tract, and host defense mechanisms (Kamruzzaman et al., 
2010; Hood & Winter, 1997; Mah & O'Toole, 2001; Hung et al., 2006). This biofilm 
state has been correlated with increased persistence and survival of V. cholerae within its 
aquatic environment (Huq et al., 2008), yet biofilms are also important for the survival 
and propagation of this bacterium within the human host (Yildiz & Visick, 2009). Recent 
evidence indicates that biofilm-specific protein antibodies are present in people that have 
been infected with cholera (Hang et al., 2003), and that bile induces the expression of 
several biofilm-specific genes (Hung et al., 2006).  
Biofilm formation appears to be necessary for effective cholera disease 
transmission, and it is believed that human ingestion of V. cholerae occurs primarily in 
 
 
2 
biofilm form (Faruque et al., 2006). The biofilm matrix protects the bacteria during 
transit through the stomach to the small intestine. However, V. cholerae bacteria must 
exit the biofilm and regain motility in order to colonize the small intestine of its host 
(Hughes et al., 1982; Schild et al., 2007). The bacterium, upon colonization of the small 
intestine, releases vast amounts of cholera toxin, an enterotoxin that elicits the 
characteristic watery diarrhea associated with the disease (Satchell, 2003).  
The regulation of the transition between biofilm formation, virulence, and motility 
is highly regulated by numerous proteins and cues in the cell that respond to 
environmental signals (Hammer & Bassler, 2003; Nikolaev & Plakunov, 2007). Some of 
the proteins involved in this process have been partially characterized (Bomchil et al., 
2003; Karatan et al., 2005); however, how they specifically interact with each other to 
regulate V. cholerae biofilm formation is yet to be elucidated, and many of the specific 
details regarding these signaling mechanisms remain unknown.  
However, it is known that many of the environmental signals and cellular 
networks that regulate biofilm formation do so by affecting cellular levels of the bacterial 
second-messenger cyclic (5’ to 3’)-diguanosine monophosphate (c-di-GMP). Cyclic di-
GMP is ubiquitous in bacteria and implicated in the regulation of numerous complex 
physiological processes (Romling & Amikam, 2006). This molecule has been found to be 
the main controller of the switch between biofilm and planktonic lifestyles in Gram-
negative bacteria (Simm et al., 2004; Tischler & Camilli, 2004). Cyclic di-GMP is 
synthesized by diguanylate cyclase enzymes containing conserved GGDEF enzymatic 
domains. These enzymes bind two molecules of GTP and cyclize them into cyclic di-
GMP (Chan et al., 2004; Ryjenkov et al., 2005). The break down of cyclic di-GMP is 
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catalyzed by phosphodiesterase enzymes containing conserved EAL or HD-GYP 
enzymatic domains. These protein domains function to break down cyclic di-GMP into 
pGpG via phosphodiesterase activity (Schmidt et al., 2005; Ryan et al., 2006). It has been 
shown in previous studies that low levels of cyclic di-GMP triggers an increase in 
motility, while high levels cause an increase in biofilm formation in V. cholerae (Jenal & 
Malone, 2006; Romling & Amikam, 2006). Evidence linking biofilm formation, cyclic 
di-GMP, and GGDEF/EAL/HD-GYP domains has revealed that when a specific 
GGDEF-domain protein in V. cholerae is overexpressed it directly upregulates the V. 
cholerae vpsA-Q genes involved in exopolysaccharide matrix production, and that this 
upregulation is directly associated with increased cyclic-di-GMP levels (Chang et al., 
2001; Hammer & Bassler, 2003; Tischler & Camilli, 2004).  
Recent characterization has revealed that a putative signaling complex in V. 
cholerae O139 composed of the periplasmic protein NspS and the putative integral 
membrane protein MbaA likely functions to regulate biofilm formation by affecting 
cellular c-di-GMP levels in response to environmental norspermidine and spermidine 
levels (Fig. 1) (Karatan et al., 2005; McGinnis et al., 2009). Norspermidine and 
spermidine are part of a class of organic polycations called polyamines. Polyamines are 
small hydrocarbon chains containing two or more primary amino groups These molecules 
are positively charged at physiological pH, and are essential for normal growth in both 
prokaryotes and eukaryotes.  
It is thought that norspermidine binds the periplasmic protein NspS, and that 
NspS interacts with the transmembrane protein MbaA and likely functions in the cyclic-
di-GMP biofilm regulatory pathway. This was concluded because deletion of the mbaA 
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gene leads to an increase in both biofilm and activity of genes encoding Vibrio 
polysaccharide synthesis and export proteins (Bomchil et al., 2003; Karatan & Watnick, 
2009; Lim et al., 2007). The NspS protein is proposed to function in this pathway since 
its ability to sense the polyamine norspermidine is associated with biofilm regulation, and 
its deletion leads to a drastic decrease in biofilm in V. cholerae (Karatan et al., 2005). 
The specific putative interaction between these two proteins is hypothesized to occur in 
the periplasmic space since NspS is a periplasmic protein and MbaA has a large 
periplasmic domain. This idea is illustrated in figure 1.  
 
Figure 1. Genomic architecture and predicted cellular locations of NspS and MbaA. 
 
Research into polyamine regulation of V. cholerae biofilms and specifically 
targeting polyamines with certain pharmaceutical drugs has been implicated as possible 
novel treatment options for cholera disease (Van Dellen & Watnick, 2006).  
 The objective of this study has been to provide evidence of definite interaction 
between constituents of a putative polyamine responsive signaling system in V. cholerae 
O139 composed of the recognized periplasmic protein NspS and the putative integral 
membrane protein MbaA. These proteins are encoded by adjacent genes and 
cotranscribed as part of an operon structure (Porter, 2009). A revealing aspect of this 
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system is the presence of both GGDEF and EAL domain motifs on the C-terminal portion 
of the MbaA protein. Because of this, we believe that MbaA likely controls dedicated c-
di-GMP pools within the cell. Since MbaA has been shown to reduce biofilm, it is likely 
functioning as a phosphodiesterase.  
 In this work we have further elucidated the molecular details of the putative 
norspermidine/spermidine-MbaA/NspS signaling system. We provide evidence of a 
direct NspS-MbaA interaction within this system. This research further characterizes the 
role periplasmic polyamine-binding proteins play in cyclic-di-GMP-mediated signal 
transduction within the first polyamine-responsive signaling system identified in bacteria. 
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MATERIALS AND METHODS 
 
Bacterial strains, plasmids, media, and reagents 
All bacterial strains and plasmids are listed in Table 1. All experiments were 
conducted with Luria-Bertani (LB) broth or agar with appropriate antibiotic unless 
otherwise indicated. V. cholerae serotype O139 strain MO10 was used for all 
experiments. Restriction endonucleases, T4 DNA ligase, and Phusion DNA polymerase 
were from New England Biolabs (Beverly, MA). Polyamines were purchased from 
Sigma (St.Louis, MO). The V5 antibody was purchased from Serotec (Raleigh, NC). 
Primer synthesis was done by MWG Biotech (High Point, NC).  DNA sequencing was 
performed by Life Sciences core facility at Cornell University (Ithaca, NY). Primers used 
for amplification, mutagenesis, and cloning are listed in Table 2.  
 
Cloning, expression, and purification of MbaA for polyclonal antibody production 
Construct Design—The portion of the mbaA gene encoding the C-terminal 
cytoplasmic domain corresponding to amino acids 260-760 was PCR-amplified using 
primers PA195 and PA196 from chromosomal V. cholerae DNA with Phusion® High-
Fidelity DNA Polymerase. These primers were designed using Vector NTI Suite (Life 
Technologies, Grand Island, NY) to add flanking NdeI and XhoI restriction enzyme 
recognition sites to the DNA construct. The PCR product was purified using Wizard® SV 
Gel and PCR Clean-Up System (Promega).  Seven µl of the purified PCR product was 
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digested in a total reaction volume of 20 µl containing 2 µl NEB buffer 4, 0.5 µl NdeI, 
0.5 µl XhoI, 0.5 µl Rnase and 9.5 µl H2O for 3 hours at 37°C and run on a 1% agarose 
gel. The resulting ~1500bp mbaA insert was gel purified using Wizard® SV Gel and PCR 
Clean-Up System (Promega) and ligated into NdeI and XhoI digested and gel purified 
pET-28b(+)vector (Novagen, Madison, WI) encoding an additional C-terminal 
polyhistidine tag for affinity purification. The ligation of pET-28b(+) and mbaA was 
performed by the addition of 5µl 10X T4 DNA ligase buffer, 4µl digested pET28(b) 
vector, 10µl digested mbaA insert, and 1µl T4 ligase  at a total volume of 20 µl with 
incubation at 16°C, overnight. The ligation was dialyzed against water using a Millipore 
dialysis disk for 30 minutes. The plasmid was electroporated into DH5α cells using a 
BIO-RAD MicroPulser (Hercules, CA) at 1.8 kV. Cells were incubated in 2mL SOC 
media (2% Tryptone, 0.5% Yeast Extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 
10mM MgSO4, 20mM D-Glucose) at 37° C for 3 hours at 180 rpm, and then plated on 
LB-Kanamycin (50 µg/mL) plates. Colony PCR was used for identification of positive 
colonies. A single colony was resuspended in 100µL deionized water in a 0.2ml PCR 
tube (ISC BioExpress, Kaysville, U.T.).  Bacterial cells were lysed by denaturation at 
95°C for 5 minutes in an Eppendorf Mastercycler (Eppendorf, Hauppauge, NY). Cellular 
debris was removed by centrifugation at 10,000 x g for 5 minutes. Two µL of the 
supernatant containing the template DNA, 5 µL 5X OneTaq Standard Reaction Buffer 
0.75 µL 10mM dNTPs, 0.2 µM of primers PA195 and PA196, and 0.125 µL OneTaq 
DNA polymerase was added at a total reaction volume of 25 µL. PCR settings were as 
follows: initial denaturation at 95° C for 5 minutes, 95° C for 30 seconds (30 cycles), 
primer annealing at 60° C for 30 seconds, an extension step at 72° C for 60 seconds, and 
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a final extension at 72° C for 5 minutes. Colonies positive for the insert were grown as 
2mL overnight cultures with 50 µg/mL kanamycin. Plasmids were purified using the 
Promega Wizard Plus SV Minipreps DNA Purification System. The sequence of the final 
construct was verified by DNA sequence analysis and the plasmid was transformed into 
chemically competent BL21(DE3) cells. Transformation was completed by the addition 
of 1µl of plasmid to 50µl BL21 cells, and subjected to heat shock of 42°C for 90 seconds.  
Cells were immediately incubated on ice for 3 minutes, then recovered for 3 hours with 
200 rpm shaking at 37°C in 2mL SOC media and plated on LB agar plates containing 50 
µg/ml kanamycin. The resulting strain, BL21(DE3) with the pET28(b)::MbaA6His 
plasmid construct, was then stored at -80 °C for downstream applications. 
Protein Expression and Purification— To overexpress the C-terminus portion of 
MbaA, E.coli BL21(DE3) cells containing the pET28(b)::MbaA6His plasmid construct 
were grown at 37 °C in LB medium and induced at an OD595 of 0.6 with 1 mM 
isopropyl-D-thiogalactopyranoside (IPTG) for 16 h at 20°C. An initial pilot experiment 
was completed by inoculating a 2mL overnight culture of BL21(DE3)  
pET28(b)::MbaA6His into 50mL LB at a 1:25 dilution. This culture was grown and 
induced as described above and revealed that the protein was mostly expressed as 
insoluble inclusion bodies. The experiment was then scaled up to 1 liter. One liter of LB 
was inoculated with a 20mL overnight culture of BL21(DE3)  pET28(b)::MbaA6His at a 
1:50 dilution, grown  and induced as described previously. The Novagen pET system 
manual was followed for the purification of inclusion body proteins. Briefly, following 
induction, the cells were harvested at 10,000 x g for 10 minutes. The supernatant was 
discarded and the cell pellet was resuspended in BugBuster Master Mix (Novagen) at 
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5mL reagent per gram of wet cell paste. The cell suspension was incubated on a shaking 
platform at a slow setting for 20 minutes at room temperature. The suspension was 
centrifuged at 16,000 x g for 20 minutes at 4 °C. The resulting insoluble cell pellet was 
resuspended in the same volume of BugBuster Master Mix used to resuspend the original 
cell pellet. Following complete resuspension of the cell pellet, 6 volumes of BugBuster 
Master Mix diluted 1:10 in deionized water was added and vortexed for 1 minute. The 
suspension was centrifuged at 5000 x g for 15 min at 4 °C to collect the inclusion bodies. 
The supernatant was removed and the inclusion bodies were resuspended in half of the 
original culture volume of 1:10 diluted BugBuster Master Mix, vortexed for 1 minute and 
centrifuged at 5000 x g for 15 min at 4 °C. This step was repeated 3 more times with the 
final centrifugation being at 16,000 x g for 15 min at 4 °C. The supernatant was discarded 
and the  inclusion bodies were resuspended in 1% SDS with heating and sonication. The 
inclusion bodies were analyzed by SDS-PAGE for purity and the MbaA C-terminal 
protein was cut from the gel and used directly for polyclonal antibody production by 
Lampire Inc. (Pipersville, PA). A total of 2mg of purified inclusion body protein was 
used for this purpose as determined by Bradford assay.  
 
Purification of polyclonal antibodies against MbaA C-terminal protein 
Affinity purification of total rabbit serum was completed using a Thermo 
Scientific Nab Spin Kit following manufacturer’s instructions. Specifically, the serum 
sample was prepared by diluting 1.5 mL sera to 2 mL in binding buffer (100 mM 
phosphate, 150 mM sodium chloride; pH 7.2). A one mL immobilized protein A/G resin 
spin column was placed in a 15 mL collection tube and centrifuged for 1 minute at 1000 
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x g to remove storage solution. The spin column was then equilibrated by adding 2 mL 
binding buffer and centrifugation at 1000 x g for 1 minute. The bottom of the spin 
column was capped and the sample was loaded onto the column and incubated at room 
temperature with end-over-end mixing for 10 minutes. The column was placed into a new 
collection tube and centrifuged for 1 minute at 1000 x g. Flow through was saved for 
downstream analysis. Spin column was transferred to another collection tube and washed 
by the addition of 2 mL binding buffer and 1 minute centrifugations at 1000 x g for a 
total of 3 washes. One hundred microliters of Neutralization buffer (1 M Tris, pH 8.5) 
was added to 3 collection tubes and the spin column was placed into the first of these 
tubes. One milliliter of IgG Elution Buffer pH 2.8 was added to the spin column and 
centrifuged for 1 minute at 1000 x g. Three elution fractions were obtained from this 
process by moving the spin column to the 2nd and 3rd collection tubes containing 
Neutralization buffer and centrifugation. The total IgG concentration of each elution 
fraction was determined using the IgG reference option on a NanoDrop 1000 
spectrophotometer. 
 
Cloning, expression, and purification of NspS 
Construct Design—The nspS gene was amplified from chromosomal V. cholerae 
DNA with Phusion® High-Fidelity DNA Polymerase without its native signal sequence 
as predicted by SignalP 4.0 using primers PA184 and PA197. This construct 
corresponded to amino acids 34-359 with primers adding flanking NcoI and XhoI 
restriction enzyme recognition sites to the DNA construct. The PCR product was purified 
using Wizard® SV Gel and PCR Clean-Up System (Promega) and then was digested with 
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NcoI  and XhoI. The nspS insert was digested by the addition of 7µl DNA, 2µl NEB 
buffer 3, 0.5 µl NcoI, 0.5µl XhoI, 0.5µl Rnase and 9.5 µl H2O for 3 hours at 37°C. The 
resulting ~1091 bp nspS insert was gel purified using Wizard® SV Gel and PCR Clean-
Up System (Promega) and ligated into the NcoI and XhoI digested and gel-purified 
pET26(b) vector (Novagen) encoding an N-terminal pelB signal sequence for periplasmic 
localization of the recombinant protein and an additional C-terminal polyhistidine tag for 
affinity purification. The ligation of pET26(b) and nspS was performed by the addition of 
5µl 10X T4 DNA ligase buffer, 4µl digested pET26(b) vector, 10µl digested nspS insert, 
and 1µl T4 ligase with incubation at 16°C, overnight. The ligation was dialyzed against 
water using a Millipore dialysis disk for 30 minutes, and then electroporated into DH5α 
cells using a BIO-RAD MicroPulser (Hercules, CA) at 1.8 kV. Cells were incubated in 
2mL SOC media at 37° C for 3 hours at 180 rpm, and then plated on LB-Kanamycin (50 
ug/mL). Colony PCR was used for identification of positive colonies as described above. 
PCR setting were initial denaturation at 95° C for 5 minutes, 95° C for 30 seconds (30 
cycles), primer annealing at 60° C for 30 seconds, an extension step at 72° C for 60 
seconds, and a final extension at 72° C for 5 minutes. Colonies positive for the insert 
were grown as 2mL overnight cultures with 50 ug/mL kanamycin. Plasmids were 
purified using the Promega Wizard Plus SV Minipreps DNA Purification System. 
Plasmids were verified by restriction digest to confirm the presence of the nspS insert. 
DNA sequencing was then used to confirm that the entire insert sequence was correct 
with no mutations.  The plasmids were then transformed into chemically competent 
BL21(DE3) cells as described above.   
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Protein Expression and Purification—The NspS6His protein was overexpressed in 
E.coli BL21(DE3). An initial pilot experiment was completed by inoculating a 2mL 
overnight culture of BL21(DE3) with  pET-26b(+)::NspS6His into 50mL LB at a 1:25 
dilution. This culture was grown at 37 °C in LB medium and induced at an OD595 of 0.6 
with 1 mM IPTG for 4 h at 37°C and revealed that while the protein was mostly 
expressed as insoluble inclusion bodies, a significant amount was expressing in the 
periplasmic space. In order to select for the greatest expression of soluble periplasmic 
proteins various induction temperatures and IPTG concentrations were tested. Final IPTG 
concentrations of 0.2 mM, 0.5 mM, 0.8 mM, 1mM, and 1.2 mM and induction 
temperatures of 16°C, 20°C, 27°C, 30°C, and 37°C were tested for this purpose and it 
was determined that 1mM IPTG at 20°C was optimum for soluble periplasmic protein 
expression. The experiment was then scaled up to 1L. One liter of LB was inoculated 
with a 20mL overnight culture of BL21(DE3) with pET-26b(+)::NspS6His at a 1:50 
dilution, grown at 37 °C in LB medium and induced at an OD595 of 0.6 with 1 mM 
IPTG for 16 h at 20°C. The Novagen pET system manual was followed for the extraction 
of periplasmic proteins. Following induction cells were harvested at 4000 x g for 20 
minutes. The supernatant was discarded and the cell pellet was resuspended in 30 mM 
Tris-HCl, 20% sucrose, pH 8.0 at 80mL per gram wet weight. Cells were kept on ice and 
0.4 ml of 500mM Ethylenediaminetetraacetic acid (EDTA) was added dropwise to a final 
concentration of 1mM. Cells were incubated on ice for 10 minutes with gentle agitation. 
This suspension was centrifuged at 8000 x g for 20 minutes at 4 °C. The supernatant was 
discarded and the cell pellet was resuspended in 200 mL of ice-cold 5mM MgSO4 and 
shaken by rotary shaker for 10 minutes. This suspension was centrifuged at 8000 x g for 
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20 minutes at 4 °C and the supernatant was recovered as the osmotic shock fluid 
containing periplasmic proteins. The periplasmic fraction was concentrated to 10 mL 
using a Millipore Amicon Ultra-15 15mL spin concentrator (Millipore, Billerica, MA) 
(molecular mass cut-off, 3 kD) and dialyzed extensively against a buffer containing 
50mM sodium phosphate, 300mM sodium chloride, 30mM imidazole at pH 7.4.  
Recombinant NspS protein was purified from the dialyzed osmotic shock fluid 
using HisPur Cobalt Resin (Thermo Fisher Scientific, Hudson, NH) using a gravity-flow 
column. Briefly, a gravity-flow column was packed with 250 µl of HisPur cobalt resin 
and equilibrated with two resin-bed volumes of equilibration/wash buffer (50mM sodium 
phosphate, 300mM sodium chloride, 30mM imidazole; pH 7.4) at a flow rate of 
0.5mL/minute. Protein sample was prepared by mixing with an equal volume of 
equilibration/wash buffer and loaded onto the column. The flowthrough was re-loaded to 
maximize binding. Resin was washed with two resin-bed volumes of equilibration/wash 
buffer until protein concentration of wash approached baseline (as determined by 
Bradford protein assay). Histadine-tagged NspS protein was eluted 3 times using one 
resin-bed volume of elution buffer (50mM sodium phosphate, 300mM sodium chloride, 
150mM imidazole; pH 7.4). Protein purity was judged by SDS- PAGE and concentration 
measured by Bradford assay. 
 
In vitro crosslinking by bis(sulfosuccinimidyl) suberate (BS3) 
 Bacterial strains were grown as 20mL overnight cultures with appropriate 
antibiotic at 37°C with shaking at 200 rpm. Cultures were harvested by centrifugation at 
10,000 x g for 3 minutes. The resulting supernatant was discarded and the cell pellet was 
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washed three times with ice-cold PBS  (20mM sodium phosphate, 0.15M NaCl, pH 8.0) 
to remove amine-containing culture media from the cells. Following the final wash, the 
pellet was resuspended in 500 µl of PBS (pH 8.0). Bis(sulfosuccinimidyl) suberate (BS3) 
crosslinker was prepared immediately before use and added to each cell suspension at a 
final concentration of 1mM. Reactions were incubated for 40 minutes at room 
temperature using a rotary shaker. Reactions were quenched upon addition of how many 
15 ul of 1M Tris, pH 7.5 at a final concentration of 20 mM. The quenching reaction was 
incubated for an additional 15 minutes before being sonicated with a 40% duty cycle for 
three 10-second pulses with at least 15 seconds between sonications using a Heat 
Systems Ultrasonics Sonicator Model W 380 (Farmingdale, NY). Samples were 
incubated on ice between pulses. The suspension was then centrifuged for 2 minutes at 
16,000 x g and the resulting supernatant stored for downstream applications.  
 
Co-immunoprecipitation 
 V5 Co-Immunoprecipitation— 20µl of agarose-immobilized goat anti-V5 
antibody (Bethyl Labs, Montgomery, TX) was incubated with 200 µl BS3 crosslinked 
whole cell protein extracts containing 120 µg of total protein  overnight at 4 °C with 
rotating. Each suspension was centrifuged for 1 min at 3000 x g. Supernatant was 
removed and saved as the unbound fraction. The V5-agarose was washed 3 times with a 
buffer containing 1% Triton-X-100 and 50mM Tris pH 8.0. Following the final wash, 
20µl of 2X SDS loading buffer (0.5M Tris-HCl pH6.8, glycerol, 10% (w/v) Sodium 
Dodecyl Sulfate (SDS) (ISC BioExpress), 0.5% (w/v) bromophenol blue (International 
Biotechnologies Inc., New Haven, C. T.), 1.4% (v/v) β-Mercaptoethanol (Fisher 
 
 
15 
Scientific) was added and boiled for 10 minutes to denature the proteins. Samples were 
separated by SDS-PAGE analyzed via Western blotting as described below. 
 
MbaA Co-Immunoprecipitation— 25µl of protein A/G agarose was incubated 
with 50µl affinity purified MbaA antibody overnight at 4 °C with rotating. The 
suspension was washed 3 times with 500µl 1X PBS to remove unbound antibody. 20µl of 
the protein A/G anti-MbaA antibody slurry was incubated with 200µl BS3 crosslinked 
whole cell protein extracts overnight at 4 °C on a rotary shaker. Each suspension was 
centrifuged for 1 min at 3000 x g. Supernatant was removed and saved as the unbound 
fraction. The V5 agarose was washed 3 times with 500 microliters of a buffer containing 
1% TritonX-100, 50mM Tris pH 8.0. Following the final wash 20µl of 2X SDS loading 
buffer was added and the sample was boiled for 10 minutes to denature the proteins. 
Samples were analyzed via Western blotting as described above. 
 
Western Blotting 
 Samples were mixed 1:1 with 2X SDS loading buffer,  boiled in water for 10 
minutes, and run on an SDS-polyacrylamide gel  with a 4-15% gradient for 40 minutes 
200 volts using a Mini-Protean 3 cell system (Biorad) in 1X Glycine Tris running buffer 
(25 mM Tris, 192 mM glycine, 0.1% SDS).  A 2 x 3.5 inch piece of PVDF membrane 
(Thermo Scientific) with dimension was soaked in methanol (EMD Chemicals, U.S.A) 
for 30 seconds and equilibrated in transfer buffer (25mM Tris, 192 mM Glycine, 0.1% 
SDS) with the gel for 30 minutes.  Proteins were transferred to a PVDF membrane using 
a semi-dry transfer cell (BioRad) at 15 volts for 25 minutes.  The PVDF membrane was 
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blocked overnight in 100mL 5% (w/v) non-fat dry milk in 1X PBST (0.1% [v/v]) Tween-
20 solution in 1X PBS) with constant slow shaking at 4°C.  The PVDF membrane was 
incubated with either a polyclonal anti-MbaA antibody at a 1:1000 concentration in 10 ml 
1X PBST for 1 hour with constant rotation, washed by three consecutive 1X PBST 
washes for 10 minutes each, incubated with an HRP conjugated goat anti-rabbit antibody 
at a 1:10,000 concentration in 10 ml 1X PBST for 1 hour with room temperature rotating 
and washed by three consecutive 1X PBST washes for 10 minutes each, or an anti-V5 
antibody (Serotec) at a 1:10,000 concentration in 10 ml 1X PBST for 1 hour with 
constant rotation, and washed by three consecutive 1X PBST washes for 10 minutes 
each. Following the wash, the membrane was incubated with SuperSignal® West Pico 
Chemiluminescent Substrate (Thermo Scientific) for 10 minutes. Membranes were 
exposed to X-ray film for 10, 30, and 45 seconds, respectively. Film was developed in a 
Konica Minolta SRX-101A developer (Konica Minolta Medical & Graphic, Inc., China). 
 
Bioinformatics 
The SignalP 4.0 server (http://www.cbs.dtu.dk/services/SignalP/) was used to 
determine where the signal peptide of NspS was located by entering the NspS FASTA 
sequence in amino acid format as obtained from NCBI (http://www.ncbi.nlm.nih.gov/). 
Domain architecture of MbaA was determined using the Simple Modular Architecture 
Research Tool (SMART) (http://smart.embl-heidelberg.de/) by entering the MbaA 
protein sequence in FASTA format as obtained from NCBI.  
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Table 1. Strains and Plasmids 
 
 
Strain/Plasmid Genotype Reference 
E. coli strains     
DH5α 
F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, mk+), 
phoA, supE44, λ-, thi-1, gyrA96, relA1 Invitrogen 
AK261 DH5α (pET26) This Study 
AK272 DH5α (pET28b::MbaA) This Study 
AK274 BL21(DE3) (pET28b::MbaA) This Study 
AK276 BL21(DE3) (pET26b::NspS) This Study 
V. cholerae O139  strains  
PW444 MO10 ΔmbaA,lacZ::vpsLp→lacZ, Smr 
(Karatan et al., 
2005) 
PW514 MO10 ΔnspS,  lacZ::vpsLp→lacZ, Smr 
(Karatan et al., 
2005) 
PW522 MO10 ΔnspS,ΔmbaA,lacZ::vpsLp→lacZ, Smr 
(Karatan et al., 
2005) 
AK007 PW514 (pACYC184) Zayner, 2008 
AK192 PW514 (pACYC184 nspS-V5)  This Study 
AK193 PW522 (pACYC184 nspS-V5) This Study 
Plasmids   
  
 
 
 
pACYC184 Tetr 
New England 
Biolabs 
pCR2.1-TOPO Plasmid for TOPO cloning, Ampr Invitrogen  
pNP1 pACYC184::nspS v5 Zayner, 2008 
pET28(b) Plasmid vector for cytoplasmic expression of recombinant proteins Novagen 
pET26(b) 
Plasmid vector for periplasmic localization and expression of recombinant 
proteins Novagen 
pET28b::mbaA6His pET28b::mbaA6His This study 
pET26b::nspS6His pET26b::nspS6His This study 
 
 
 
Table 2. Primers 
 
 
Primer Description Sequence 
P215 Forward primer 99bp upstream of NspS 5'-GCGACCAAATTATACATAGAG-3' 
PA24 Reverse primer for nspS 5'-GCTGCCATGGCTACGTAGAATCG-3' 
PA184 Reverse primer for pET28b::NspS 5’-TGTCTCGAGTGGTTTAGCTTCATATTGG-3’ 
PA195 Forward primer for pET28b::MbaA 5’-AAGCATATGGTGATCAATCCGATCCTGC-3’ 
PA196 Reverse primer for pET28b::MbaA 5’-TGTCTCGAGCTAACGGCATTCACTTTGGC-3’ 
PA197 Forward primer for pET26b::NspS 5’-AAGCCATGGTGGAACTCAATCTCTACCTT-3’ 
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RESULTS 
 
 
Construction of plasmid for expression of the c-terminal fragment of MbaA 
 
 
 In an effort to provide conclusive evidence of an interaction between NspS and 
MbaA, I determined that coimmunoprecipitation experiments would allow me to show 
interaction between the two proteins in a straightforward manner. Previous work in the 
lab resulted in the engineering of a V5 epitope tag onto the NspS protein for which a 
commercial antibody was readily available (Zayner, 2008). The primary complication of 
this experiment was that we did not have an available antibody for the MbaA protein. To 
solve this problem, the pET-28b(+) cytoplasmic expression system was utilized for the 
cloning, expression, and purification of the MbaA protein. This protein would be used 
directly for immunization into rabbits for polyclonal antibody production. The MbaA 
protein is a large integral membrane protein with multiple domain motifs (Figure 2A). 
Specifically, the domain architecture of the MbaA protein includes GGDEF and EAL 
domains known to function in c-di-GMP signaling, a HAMP linker domain (present in 
Histidine kinases, Adenyl cyclases, Methyl-accepting proteins, and Phosphatases) often 
found in conjuction with GGDEF/EAL domains, and several transmembrane domains. It 
has been suggested that HAMP domains play a role in regulating the phosphorylation or 
methylation of homodimeric receptors by transmitting the conformational changes in 
periplasmic ligand-binding domains to signal kinase and methyl-acceptor domains. 
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Figure 2A. Genomic architecture and predicted cellular locations of NspS and 
MbaA. 
 
  It was determined that the protein’s large size and transmembrane region would 
make it difficult to purify in large enough amounts for use in antibody production. For 
this reason, the region encoding the  C-terminal cytoplasmic portion of the protein 
containing the GGDEF and EAL domains was cloned into pET-28b(+) as described in 
Materials and Methods. The overall procedure involved from plasmid construction to 
protein purification is illustrated in Figure 2B. I cloned and ligated the MbaA C-terminal 
fragment. This construct was transformed into E. coli DH5α cells as a non-expression 
host to propagate  the plasmid and positive clones were identified using colony PCR. The 
plasmid was then transformed into BL21(DE3) cells. These cells carry the T7 RNA 
polymerase gene required for expression of the target gene using IPTG induction. Four 
colonies were checked for the presence of the 1500bp C-terminal fragment by restriction 
digest (Figure 2C).  
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Figure 2B. Flowchart of cloning of a fragment encoding C-terminal MbaA protein.  
 
 
  
Figure 2C. Confirmation of the mbaA insert in pET-28b(+)::MbaA6His construct. 
Four isolated colonies were digested with NdeI and XhoI and run on a 1% agarose gel. 
An arrow indicates the mbaA insert predicted to be 1500bp. SM: size marker, lane 1: 
colony 1; lane 2: colony 2; lane 3: colony 3; lane 4: colony 4.  
 
 
Purification of MbaA C-terminal fragment for polyclonal antibody production 
 
 Once the pET-28b(+)::MbaA6His plasmid was transformed into BL21(DE3) E. 
coli cells the new strain was tested for its ability to express the recombinant protein using 
IPTG induction. This pilot expression was performed as outlined in the methods section. 
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The addition of IPTG induces transcription of the T7 RNA polymerase present in 
BL21(DE3) cells. This bacteriophage T7 RNA polymerase hijacks the cells’ resources 
and devotes a significant amount of materials toward target gene expression. To facilitate 
verification of protein expression, cells were harvested and fractionated into total cellular 
protein, soluble cytoplasmic protein, insoluble cytoplasmic protein, and medium 
fractions. The culture medium was also checked for target protein leakage from cells 
since the culture was induced for an extended period of time. Uninduced controls were 
utilized to determine if induction and expression was successful (Figure 3).  
SDS-PAGE analysis and Coomassie staining revealed that IPTG induction was 
successful as judged by the 55 kD band seen in the induced total cell protein fraction and 
not seen in the uninduced control. However, staining also determined that the bulk of the 
recombinant protein (>80%) was located in the insoluble cytoplasmic fraction. A limited 
amount of recombinant protein was seen in the soluble cytoplasmic fraction. No 
appreciable amounts of protein were seen in the media fractions, indicating that target 
protein leakage did not occur. Following this analysis the entire procedure was scaled up 
to induce a 1L culture. Inclusion bodies were purified from this culture as outlined in the 
methods, and gel slices of the recombinant MbaA inclusion body proteins were prepared 
using SDS-PAGE. Gel slices corresponding to approximately 2mg of C-terminal MbaA 
protein was used directly for polyclonal antibody production.  
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Figure 3.  Expression and localization of recombinant MbaA C-terminal protein. 
Cellular fractionations were separated by SDS-PAGE and stained with Coomassie 
brilliant blue. An arrow indicates the MbaA protein fragment predicted to be 55kD. SM: 
size marker, lane 1: induced insoluble fraction (inclusion bodies); lane 2: uninduced 
insoluble fraction; lane 3: uninduced soluble cytoplasmic fraction; lane 4: induced 
soluble cytoplasmic fraction; lane 5: induced cellular media fraction; lane 6: uninduced 
cellular media fraction; lane 7: induced total cellular protein; lane 8: uninduced total 
cellular protein.  
 
Purification of polyclonal antibodies against MbaA C-terminal protein 
 In order to reduce nonspecific binding of total serum proteins during 
immunoblotting, immunoaffinity chromatography was used to isolate polyclonal 
antibodies from sera of rabbits immunized with MbaA C-terminal protein. Affinity 
purified antibody is necessary for accurate coimmunoprecipitation assays as nonspecific 
binding of contaminating serum proteins makes the isolation and detection of relevant 
immunoprecipitated protein complexes significantly more challenging. A Thermo 
Scientific Nab Spin Kit was used for affinity purification and involved the use of 
microcentrifuge spin columns pre-filled with immobilized protein A/G resin. Protein A/G 
is useful for binding a broad range of IgG subclasses as it is a recombinant fusion protein 
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that incorporates the IgG binding domains of both protein A and protein G. A spin 
purification protocol was followed as described in Materials and Methods. Non-IgG 
contaminants were washed from the spin column with binding buffer and the purified 
IgG was eluted using a pH 2.8 elution buffer. Three elution fractions were obtained and 
purity was determined by SDS-PAGE. The concentration of IgG in each elution fraction 
was determined using the IgG reference option on a NanoDrop 1000 spectrophotometer. 
IgG is composed of a four chain structure including two light chains at 23kD and two 
heavy chains at 50-70kD. Purified IgG fractions show clear presence of both heavy and 
light IgG chains and no other proteins, suggesting that the antibodies were highly purified 
from total serum proteins (Figure 4).  
 
 
 
Figure 4. Affinity purification of the polyclonal MbaA antibody. Purification was 
accomplished as described in Materials and Methods. SM: size marker, lane 1: total 
serum; lane 2: unbound serum flow through; lane 3: wash 1; lane 4: wash 3; lane 5: 
elution 1; lane 6: elution 2; lane 7: elution 3. Arrows represent both IgG heavy (top) and 
light (bottom) chains, respectively. 
 
 
Testing of anti-MbaA polyclonal antibody 
 
 It was important to evaluate the specificity of the MbaA antibody in order to 
properly optimize conditions for its use both in western blotting and immunoprecipitation 
experiments. An Elisa was performed using purified MbaA C-terminal protein, which 
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showed that the antibody was specific to the purified protein. A western blot of purified 
protein further confirmed that the antibody was protein specific (Data not shown). We 
proceeded to run a western blot with the anti-MbaA affinity-purified antibody using V. 
cholerae w/ pACYC184 nspS-V5 and V. cholerae w/ ΔmbaA/pACYC184 nspS-V5 
strains. The MbaA protein has a calculated mass of 91kD and the western blot revealed a 
band at around this size in the V. cholerae strain with MbaA present and a band was not 
seen in the strain with MbaA deleted (Figure 5.).  
 
 
Figure 5. Detection of MbaA in whole cell extracts. The 91 kD MbaA monomer is 
indicated by an arrow. SM: size marker, lane 1: V. cholerae w/ ΔmbaA/pACYC184 nspS-
V5; lane 2: buffer lane; lane 3: V. cholerae w/ pACYC184 nspS-V5. 
 
 Interestingly, several other bands of lower size were present on the western blot. 
Specifically two bands at approximate sizes of 80 kD and 60 kD were consistently 
observed during extended testing of the antibody in all V. cholerae lysates tested. 
Nevertheless, this testing provided direct evidence of a band of appropriate size for the 
MbaA protein that was not present in strains carrying an MbaA deletion.  
 
Bis(sulfosuccinimidyl) suberate (BS3) crosslinking reveals NspS dimerization and 
NspS/MbaA heterodimer 
 Once it had been verified that the MbaA antibody was specific to purified protein, 
it was used to test the interaction between NspS and MbaA. Initial 
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coimmunoprecipitation experiments using the MbaA antibody did not reveal the presence 
of NspS in the MbaA immunoprecipitation complex during western blot analysis. I 
performed the reciprocal experiment using agarose-immobilized anti-V5 antibody in an 
attempt to capture the putative NspS/MbaA complex using the V5 antibody. A silver 
stain of this immunoprecipitation revealed that NspS was being captured by the V5 
antibody, but that no other protein bands corresponding to the molecular weight of MbaA 
(91 kD) were observed. The two other bands present in the silver stain correspond to the 
heavy and light chains of the antibody IgG. (Figure 6).  
This observation led to a hypothesis that perhaps NspS and MbaA were in fact 
interacting but lysis and wash conditions during Co-IP were disrupting the complex and 
preventing our ability to pick it up with the V5 antibody. In order to overcome this 
potential obstacle I utilized the bifunctional N-hydroxysulfocuccinimide (NHS) ester, 
bis(sulfosuccinimidyl) suberate (BS3). This crosslinking reagent, which reacts with free 
primary amines in proteins, is water soluble and membrane-impermeable and can 
effectively covalently crosslink interacting proteins on the inner membrane and the 
periplasmic space, hypothesized to be the location of NspS/MbaA interaction. This 
crosslinking reagent was incubated with both V. cholerae w/ pACYC184 nspS-V5 and V. 
cholerae w/ ΔmbaA/pACYC184 nspS-V5 strains as described in Materials and Methods. 
Initial crosslinking experiments were performed, followed by SDS-PAGE and Western 
blot with the V5 antibody. Previous use of this antibody using strains carrying the 
pACYC184 nspS-V5 plasmid consistently resulted in a single 40 kD band corresponding 
to a NspS monomer (Figure 6). However, upon crosslinking the same strain revealed two 
additional bands, one at 80 kD and another at 130 kD. We hypothesized the 80 kD band 
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to correspond to an NspS homodimer. Interestingly the 130 kD band was not seen in 
strains carrying an MbaA knockout. This led to the hypothesis that the 130 kD band 
corresponds to an MbaA/NspS heterodimer composed of the 91 kD MbaA protein and 
the 40 kD NspS protein (Figure 7.).  
 
Figure 6. Silver stain of the immunoprecipitation complex using V5 agarose. The 40 
kD NspS monomer is indicated by an arrow. SM: size marker; lane 1: Total cell protein 
of V. cholerae w/ pACYC184 nspS-V5; lane 2: Total cell protein of V. cholerae w/ 
ΔmbaA/pACYC184 nspS-V5; lane 3: unbound flowthrough of V. cholerae w/ 
pACYC184 nspS-V5; lane 4: unbound flowthrough of V. cholerae w/ 
ΔmbaA/pACYC184 nspS-V5; lane 5: wash 1 of V. cholerae w/ pACYC184 nspS-V5; 
lane 6: wash 1 of V. cholerae w/ ΔmbaA/pACYC184 nspS-V5; lane 7: IP of V. cholerae 
w/ pACYC184 nspS-V5; lane 8: IP of V. cholerae w/ ΔmbaA/pACYC184 nspS-V5. 
 
It is important to note that protein concentrations for western blotting were always 
normalized and that crosslinked V. cholerae w/ ΔmbaA/pACYC184 nspS-V5 
consistently revealed a much weaker signal for the 80 kD band even as the 40 kD band 
maintained an equal level of expression with the V. cholerae w/ pACYC184 nspS-V5 
strain (Figure 8).  
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Figure 7. Effect of BS3 crosslinking on V. cholerae and V. cholerae w/ΔmbaA. SM: 
size marker; Lane 1: V. cholerae w/ pACYC184 nspS-V5; lane 2: buffer lane; lane 3: V. 
cholerae w/ pACYC184 nspS-V5 crosslinked; lane 4: buffer lane; lane 5: V. cholerae w/ 
ΔmbaA/pACYC184 nspS-V5; lane 6: buffer lane, lane 7: V. cholerae w/ 
ΔmbaA/pACYC184 nspS-V5 crosslinked. Arrows indicate the NspS monomer, 
homodimer, and NspS/MbaA heterodimer. 
 
 
 
 
Figure 8. Effect of BS3 crosslinking on NspS dimerization and complex formation. 
SM: size marker; Lane 1: crosslinked V. cholerae w ΔmbaA/ pACYC184 nspS-V5; lane 
2: crosslinked V. cholerae w/ pACYC184 nspS-V5. 
 
Immunoprecipitation provides evidence of NspS/MbaA interaction 
 The above experiments revealed chemical crosslinking using BS3 was effective in 
stabilizing the MbaA/NspS protein interaction in order to allow for successful co-
immunoprecipitation experiments. Due to the consistent specificity of the anti-V5 
antibody in revealing the NspS dimer and putative NspS/MbaA heterodimer (Figure 8) 
we decided to use agarose-immobilized anti-V5 antibody to capture the NspS/MbaA 
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complex and test for the presence of MbaA using standard western blotting procedures. 
The western blot revealed the presence of a single 130 kD band in the V. cholerae w/ 
pACYC184 nspS-V5 strain and no such band in the V. cholerae w/ ΔmbaA/pACYC184 
nspS-V5 strain (Figure 9). It is especially compelling that the same 130 kD band was 
picked by the anti-V5 antibody upon on a subsequent western blot using remaining cell 
sample from the previous western blot.  
 
 
 
Figure 9. Co-immunoprecipitation of NspS/MbaA using anti-MbaA antibody. The 
130 kD MbaA heterodimer is indicated by an arrow. SM: size marker; Lane 1: IP 
flowthrough of V. cholerae w/ pACYC184 nspS-V5; lane 2: IP of V. cholerae w/ 
pACYC184 nspS-V5; lane 3: buffer lane; lane 4: IP flowthrough of V. cholerae w 
ΔmbaA/ pACYC184 nspS-V5; lane 5: IP of V. cholerae w/ ΔmbaA/pACYC184 nspS-V5. 
 
 
This experiment clearly demonstrated that the covalent crosslinking of proteins in both V. 
cholerae strains was effectual in maintaining the NspS/MbaA complex during wash/lysis 
steps that were potentially disrupting the complex without the presence of the crosslinker. 
This phenomenon reveals the MbaA/NspS association to be potentially weak and 
possibly transient. It was difficult to determine from the western blot but a light smear 
above the 130 kD band may further correspond to a possible heterotetramer of 
MbaA/NspS; however, this possibility has yet to be confirmed experimentally. Attempts 
to stain an SDS-PAGE gel of these crosslinked co-immunoprecipitations with Coomassie 
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Brilliant Blue have been inconclusive due to extremely faint bands in the gel. If we could 
pick up bands at relevant sizes using SDS-PAGE we could potentially use MALDI-TOF 
mass spectrometry to determine exactly what proteins are present in the sample.  
 
Addition of polyamines may cause a conformational change in the MbaA/NspS 
complex but does not affect complex formation 
 
Previous studies have revealed that exogenous norspermidine increased biofilm 
formation in a NspS-dependent manner and that norspermidine was a signal under these 
conditions (Karatan et al., 2005).  Further spermidine addition significantly inhibits 
biofilm formation in an MbaA-dependent manner (McGinnis, 2009). Since MbaA and 
NspS are believed to interact in order to affect biofilm formation I hypothesized that 
performing co-immunoprecipitation experiments using V. cholerae w/ pACYC184 nspS-
V5 and V. cholerae w/ΔmbaA/pACYC184 nspS-V5 grown as overnight cultures with the 
presence of increasing norspermidine or spermidine concentrations may provide insight 
into this effect. Immunoprecipitations were performed as described in Materials and 
Methods and the western blots were probed with anti-V5 antibody to determine if an 
appreciable effect on dimerization and complex formation could be determined. The 
results of this experiment suggested that there was no perceptible change in the effect of 
dimerization and complex formation resulting from increasing polyamine concentrations 
(Figure 10A, 10B). However, as stated previously the amount of dimerization and other 
complex formation was significantly less in the MbaA knockout strain.  
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Figure 10A. Polyamine effect on MbaA/NspS complex in V. cholerae. SM: size 
marker, lane 1: V. cholerae w/ pACYC184 nspS-V5; lane 2: buffer lane; lane 3: 100 µM 
spermidine; lane 4: 500 µM spermidine; lane 5: 1000 µM spermidine; lane 6: 100 µM 
norspermidine; lane 7: 500 µM norspermidine; lane 8: 1000 µM norspermidine. 
 
 
 
 
Figure 10B. Polyamine effect on MbaA/NspS complex in V. cholerae w ΔmbaA. SM: 
size marker, lane 1: V. cholerae w ΔmbaA/ pACYC184 nspS-V5; lane 2: buffer lane; lane 
3: 100 µM spermidine; lane 4: 500 µM spermidine; lane 5: 1000 µM spermidine; lane 6: 
100 µM norspermidine; lane 7: 500 µM norspermidine; lane 8: 1000 µM norspermidine. 
                                                
Construction of plasmid for expression of NspS            
                                                                    
 In an effort to determine whether norspermidine and spermidine are ligands to 
NspS a pET-26b(+) periplasmic expression system was utilized for the cloning, 
expression, and purification of NspS protein for use in ligand binding assays (Figure 11). 
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Figure 11. Flowchart of cloning and ligation of the nspS gene using pET-26b(+).  
 
 
 
 
Figure 12. Amplification of nspS insert using Phusion® Polymerase. The 1080 bp 
insert is indicated by an arrow. SM: size marker; lane 1: buffer lane; lane 2: nspS insert. 
 
 The 1080bp nspS gene was PCR-amplified from chromosomal V. cholerae DNA 
(Figure 12). This insert was purified and cloned into pET-26b(+) as described in 
Materials and Methods. The overall procedure involved from plasmid construction to 
protein purification is illustrated in Figure 10. This construct was transformed into E. coli 
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DH5α cells as a non-expression host to propagate the plasmid, and positive clones were 
identified using colony PCR. The plasmid was then transformed into BL21(DE3) cells 
for expression of the target gene using IPTG induction. DNA sequencing was used to 
verify that the entire insert sequence was correct with no mutations and isolated plasmids 
were verified by restriction digest to confirm the presence of the nspS insert. (Figure 13).  
 
 
 
 
Figure 13. Confirmation of the nspS insert in pET-26b(+)::NspS6His construct. Two 
isolated colonies were digested with NcoI and XhoI and run on a 1% agarose gel. The 
nspS insert predicted to be 1080bp is indicated by an arrow. SM: size marker, lane 1: 
colony 1; lane 2: colony 2.   
 
 
Since NspS is a periplasmic protein we decided to use the pET-26b(+) vector since it 
encodes an N-terminal pelB signal sequence for periplasmic localization of the 
recombinant protein and an additional C-terminal polyhistidine tag for affinity 
purification. In an effort to acquire meaningful data we believed that only NspS protein 
that was shuttled to the periplasm and subsequently processed could be definitively 
expected to exist in its native folded conformation. We judged that only natively folded 
soluble protein would be effective for binding assays since this conformation most 
closely resembles what we hypothesize to be the conformation NspS exists as during its 
interaction with MbaA.  
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Purification of NspS for use in ligand binding studies 
 
Once the pET-26b(+)::NspS6His plasmid was transformed into BL21(DE3) E. coli cells 
the new strain was tested for its ability to express the recombinant protein using IPTG 
induction. This pilot expression was  performed as outlined in the methods section. To 
facilitate protein verification a small-scale analysis was performed using cells harvested 
and fractionated into total cellular protein, soluble cytoplasmic protein, insoluble 
cytoplasmic protein, and periplasmic proteins. SDS-PAGE analysis and Coomassie 
staining revealed that IPTG induction was successful as judged by the notable 40 kD 
band seen in all fractions. However, staining also determined that the bulk of the 
recombinant protein (>80%) was located in the insoluble cytoplasmic fraction similarly 
to the pET-28b(+)::MbaA6His construct. A significant amount of NspS was also found in 
the periplasmic fraction as expected for this vector (Figure 14.).  
 
Figure 14. Expression and localization of recombinant NspS protein. Cellular 
fractionations were separated by SDS-PAGE and stained with Coomassie brilliant blue. 
The NspS protein predicted to be 40kD is indicated by an arrow. SM: size marker, lane 1: 
buffer lane; lane 2: total cellular protein fraction; lane 3: buffer lane; lane 4 induced 
periplasmic fraction; lane 5: buffer lane; lane 6: induced soluble cytoplasmic fraction; 
lane 7: buffer lane; lane 8: induced insoluble cytoplasmic fraction (inclusion bodies). 
 
Following this analysis the entire procedure was scaled up to induce a 1L culture. 
Periplasmic proteins were obtained using the osmotic shock method outlined in Materials 
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and Methods. These proteins were concentrated to 10 mL and dialyzed extensively 
against a lysis buffer containing 50mM sodium phosphate, 300mM sodium chloride, and 
30mM imidazole at pH 7.4. Following dialysis NspS was purified from total periplasmic 
proteins using metal affinity chromatography. HisPur cobalt resin was used for this 
purpose. HisPur is a tetradentate chelating resin charged with divalent cobalt (Co2+) that 
allows for purification of histidine-tagged recombinant proteins due to the affinity of 
histidine for the metal ions. Cobalt resin was chosen over nickel-NTA due to cobalt’s 
higher specificity for histidine-tagged proteins with lower nonspecific binding. A general 
procedure was completed following isolation and dialysis of periplasmic proteins from 
BL21(DE3) carrying the pET-26b(+)::NspS6His plasmid as per manufacturer’s 
instructions and is outlined in figure 15.  
 
 
Figure 15. General purification scheme using HisPur cobalt resin to purify NspS. 
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The wash conditions were optimized from 5 mM imidazole to 40 mM in order to remove 
nonspecifically bound contaminating proteins. Following the completed purification, all 
fractions were analyzed using SDS-PAGE in order to evaluate protein purity (Figure 16). 
The single large band seen in each elution fraction confirmed the purity of the 
periplasmic NspS protein. The elution fractions were then dialyzed to remove high 
imidazole concentrations and stored for use in binding studies with its proposed ligands, 
norspermidine and spermidine.  
 
 
 
Figure 16. Purification of periplasmic NspS protein using HisPur cobalt resin. The 
NspS protein predicted to be 40kD is indicated by an arrow. SM: size marker, lane 1: 
buffer lane; lane 2: periplasmic protein flowthrough; wash 1; lane 4: wash 3; lane 5: 
buffer lane; lane 6: elution 1; lane 7: elution 2.  
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DISCUSSION 
 
 In this work I have further characterized NspS and MbaA, two protein 
constituents of a putative polyamine responsive signaling system in V. cholerae O139. 
The purpose of this study has been to explore several aspects of this putative signaling 
system. Specifically, I aimed to 1: provide evidence for NspS/MbaA interaction, and 2: to 
establish that spermidine and norspermidine are ligands for NspS. I engineered a 
recombinant MbaA C-terminal protein fragment and used it to generate a polyclonal 
antibody to MbaA. This antibody was used together with the membrane-impermeable 
crosslinking reagent BS3 to provide direct evidence of an interaction between these two 
proteins. The crosslinking reagent in conjunction with a V5 epitope engineered on the 
NspS protein revealed that NspS forms a dimer and that this dimerization is significantly 
increased in the presence of MbaA. I also determined from Western blot analysis of 
crosslinked strains that a protein band at approximately 130 kD likely corresponds to an 
NspS (40 kD) and MbaA (91 kD) heterodimer since this band was not seen in strains 
carrying an MbaA deletion. These results further indicated that while previous studies 
show that exogenous norspermidine increases V. cholerae biofilm formation in an NspS 
and MbaA-dependent manner, crosslinking studies performed on cell cultures grown in 
the presence of increasing norspermidine and spermidine levels did not reveal 
appreciable differences in their dimerization profiles. This result indicated that the 
polyamines could be affecting NspS by causing a conformational change in the protein 
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that could alter its interaction with MbaA but not change its capacity to dimerize. Finally, 
I was able to develop a recombinant NspS protein construct using the periplasmic 
expression vector pET-26b(+). Previous studies indicate that NspS is necessary to 
moderate the effects of spermidine and norspermidine on V. cholerae biofilm formation. 
NspS is annotated as belonging to a family of periplasmic polyamine-binding proteins. 
This data taken together suggests a likelihood of norspermidine and spermidine acting as 
direct ligands for NspS. Since this hypothesis has never been proven, we hope to test this 
prediction using these polyamines and purified NspS protein with isothermal titration 
calorimetry.  
 In V. cholerae, the switch between biofilm and planktonic lifestyles is a tightly 
regulated process. A complex system of signaling pathways is used to mediate this 
transition, and uses a wide range of environmental cues as inputs. The basis and central 
regulator of this regulatory system is the bacterial second messenger, cyclic-di-GMP. 
Specifically, GGDEF and EAL domain proteins direct intracellular c-di-GMP levels in 
response to environmental signals, and c-di-GMP levels control the transition between 
biofilm and planktonic lifestyles.  
 The V. cholerae genome encodes a total of 61 proteins directly involved in c-di-
GMP synthesis and degradation. These include 12 with EAL domains, 31 with GGDEF 
domains, 10 with tandem GGDEF/EAL domains, and 9 with HD-GYP domains 
(Heidelberg et al., 2000). Due to the vast amount of these domains present in V. cholerae, 
it is easy to assume that a plethora of environmental signaling inputs should be available 
for initiating cyclic-di-GMP regulatory networks. However, to date only a handful of 
environmental signals believed to be transmitted and perceived by c-di-GMP signaling 
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systems have been elucidated.  
 Within many of the currently studied c-di-GMP biofilm regulatory systems the 
central c-di-GMP-dependant regulator is a specific phosphodiesterase enzyme. Previous 
work in our lab has demonstrated that increased levels of the polyamine norspermidine 
lead to increases in biofilm formation in V. cholerae through the action of the periplasmic 
protein NspS (Karatan et al., 2005). The V. cholerae transmembrane protein MbaA is 
part of a group of GGDEF and EAL domain-containing regulatory proteins. MbaA is 
believed to function in the cyclic-di-GMP biofilm regulatory pathway since an absence of 
the mbaA gene leads to an increase in both biofilm proportion and transcription of genes 
encoding proteins utilized in Vibrio polysaccharide synthesis (Bomchil et al., 2003; 
Karatan et al., 2005). These vps genes are fundamental biofilm elements functioning in 
the biofilm regulatory pathway. The NspS protein is also proposed to function in this 
pathway since its ability to sense the polyamine norspermidine is associated with biofilm 
regulation, and its deletion leads to a drastic decrease in biofilm. MbaA is a known 
repressor of biofilm formation and vps gene expression and so it is likely that MbaA 
functions as a phosphodiesterase to break down c-di-GMP (Bomchil et al., 2003; Karatan 
et al., 2005; Karatan & Watnick, 2009). Since NspS is known to promote biofilm 
formation and MbaA is known to hinder biofilm formation, it is likely that inhibition of 
MbaA activity is mediated by NspS via a putative NspS/MbaA signaling system reactive 
to polyamines that works to regulate biofilm formation, vps gene expression, and cyclic-
di-GMP levels in V. cholerae.    
 In order to address the first specific aim of this study, we utilized co-
immunoprecipitation experiments. Co-immunoprecipitation is a proven method to 
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address protein-protein interactions that uses an antibody to immunoprecipitate a specific 
known protein antigen and co-immunoprecipitate any interacting proteins that may be 
part of larger protein signaling complexes. Initial co-immunoprecipitation assays did not 
indicate that NspS and MbaA were interacting due to the inability to pick up an 
NspS/MbaA complex using standard co-immunoprecipitation protocols. In order to 
overcome this initial setback, I decided to crosslink the cell lysates using the NHS ester 
BS3. I discovered that upon crosslinking the V. cholerae strain containing the V5-tagged 
NspS protein and probing for the V5-tagged NspS using immunoblotting, several bands 
emerged that had not been seen previously. Without crosslinking I saw one band at 40 kD 
corresponding to a monomer of NspS but crosslinking revealed  bands at 40 kD, 80 kD, 
and 130 kD. I have hypothesized the 80 kD band to be a likely NspS homodimer. The 
130 kD band was not present in crosslinked cell lysates that had mbaA gene deletions. 
Since MbaA is believed to be 91 kD in size, I hypothesized that the 130 kD band 
corresponded to an MbaA/NspS heterodimer. In order to address this I am attempting to 
Coomassie stain these SDS-PAGE gels in order to use MALDI-TOF mass spectrometry 
to confirm my hypothesis. Presently stained protein bands are too weak to be identified 
by the mass spectrometer; however, attempts to concentrate the protein complexes using 
anti-V5 antibody immobilized agarose are currently underway. The inability to pick up 
the NspS/MbaA interaction under the conditions tested without the use of a chemical 
crosslinker indicated that the interaction is likely a transient one. Transient protein 
complexes are important in the regulation of signaling pathways in the cell because they 
enable the cell to quickly respond to external stimuli. The presence of both monomers 
and homodimers of NspS under crosslinking conditions indicates that both forms of the 
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protein may be involved in the interaction with MbaA. For example, an NspS monomer 
may be active during the binding process with its polyamine ligand, but an NspS dimer 
may be required for its interaction with MbaA. It was interesting to see that when protein 
concentrations were normalized between samples, strains carrying an MbaA knockout 
consistently showed a much lower degree of NspS dimerization. Previous research in our 
lab has determined from cellular fractionation assays that increasing concentrations of 
exogenous norspermidine led to a greater amount of NspS protein partitioning into the 
membrane fraction from the periplasm where it is hypothesized to interact with MbaA 
(Zayner, 2008). Also when MbaA is deleted, NspS is not found in the membrane fraction. 
It would be interesting to use the crosslinker to determine which fraction the NspS 
homodimer is located in and if it is located in the membrane fraction whether or not 
exogenous norspermidine increases its presence in the membrane fraction.  
 NspS crosslinking experiments performed in the presence of increasing levels of 
spermidine and norspermidine indicated that the presence of the polyamine does not 
appear to drastically alter the amount of the NspS homodimer. However, since the 
experiment was carried out using whole cell extracts it is unknown if the amount of 
homodimer is altered in specific cellular locations. Again, cellular fractionations using 
the crosslinker could shed light on this possibility. Previous research regarding this 
pathway has shown that NspS and MbaA interaction is independent of norspermidine and 
spermidine since norspermidine is not found in LB culture media but that these 
polyamines likely modulate the NspS/MbaA interaction.   
 In order to address the second aim of this study, I decided to clone, express, and 
purify recombinant NspS protein for use in binding studies with its proposed polyamine 
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ligands: norspermidine and spermidine. This was accomplished using the Novagen pET-
26b(+) vector system. The NspS protein is believed to interact directly with the 
polyamine norspermidine to induce a conformation change in the protein allowing 
interaction with MbaA. I cloned the NspS protein lacking the native signal sequence into 
the pET26b+ (Novagen) vector encoding a N-terminal pelB leader sequence for 
periplasmic localization of the recombinant protein in addition to a c-terminal histidine 
tag for affinity purification. The objective of this construct was to purify this recombinant 
protein and use it directly for isothermal titration calorimetry assays to determine binding 
affinity. If successful this experiment will establish the existence of the first polyamine-
binding protein involved in signal transduction rather than transport discovered in 
bacteria, opening the door for research into an entirely novel class of proteins.  
 The NspS protein has a number of homologs present in a wide range of bacteria, 
all of which are periplasmic ATP binding cassette (ABC)-type transporter ligand-binding 
proteins. All of these proteins identified to date are known to either be parts of transport 
systems or parts of transport systems that also have a role in signaling. Two NspS 
homologs exist in V. cholerae and are designated PotD1 and PotD2. These homologs 
function in an ABC-type transport system used in the import of polyamines into the cell. 
However, the NspS protein is different. Recent evidence indicates that NspS cannot 
transport spermidine or norspermidine and thus is likely involved exclusively in signaling 
(Rutkovsky, unpublished results). This hypothesis is supported by the nspS gene being 
adjacent to mbaA on the chromosome (Porter, 2009). This suggests that NspS may be part 
of a subset of the ABC-type polyamine-binding transport protein family that is involved 
in signaling but not transduction. A comparative genomic analysis revealed that 
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nspS/mbaA-like gene pairs are present in the genomes of several closely related Vibrio 
species (V. vulnificus, V. parahaemolyticus) and in several distantly related 
proteobacteria including Pseudomonas stutzeri, Hahella chejuensis, and Psychromonas 
ingrahamii (Porter, 2009). None of these systems have been characterized to date, but the 
existence of these conserved gene pairs in other bacteria indicate that polyamine-
responsive signaling systems that use c-di-GMP may be widely utilized by bacteria. 
Therefore, characterization of the NspS/MbaA signaling system in V. cholerae will 
provide insight into how these systems may be functioning within other bacterial species.  
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